of efflux blockers, laser flow cytometry is a useful tool for
In a previous publication we reported on the flow cytometric and immunocytochemical comparison of three anti-P-glycoprotein antibodies (C219, JSB1 and MDR-Ab 1 ) which recogIntroduction nize the cytoplasmic component of the P-glycoprotein. 10 However, a major part of the P-glycoprotein is believed to Cellular resistance may be a major factor for failure of cancer reside in the cell membrane with only a small portion on the chemotherapy in refractory patients. Studies over the last decouter cell surface. Recently, three new monoclonals which ade have identified multiple drug resistance (MDR) as a cellurecognize the outer cell membrane resident portion of the Plar protective mechanism which confers resistance to a variety glycoprotein have been described. [11] [12] [13] In the present study, of chemically unrelated natural products used in cancer we have compared expression of these three monoclonals chemotherapy. It is evident from the numerous studies pub-(MRK16, UIC2 and 4E3) in a panel of human tumor cell lines lished during the last decade that MDR is multifactorial and with MDR 1 related drug efflux. involves not only drug efflux, but also intracellular drug distribution, detoxification, DNA synthesis and repair. 1, 2 Rapid drug efflux mediated by a cell membrane resident PMaterials and methods glycoprotein (P-gp) has been shown to reduce cellular drug retention and chemosensitivity. Recent studies have identified Human lymphocytes from the venous blood of a donor were MRP and LRP as two other drug resistance related proteins retrieved by separation on a Ficoll-Hypaque gradient involved in cellular drug transport, subcellular distribution (Histopaque 1077; Sigma Chemical, St Louis, MO, USA) The and resistance. 3, 4 mononuclear cells were washed and resuspended in miniBesides immunocytochemistry which depends on the use of mum essential medium and 4% heat inactivated fetal bovine monoclonal antibodies for identification of cellular resistance serum. The lymphocytes, at a starting concentration of markers, fluorescent microscopy and confocal microscopy 1 × 10 6 /ml, were cultured in flasks containing 18 ml of cell and laser flow cytometry have been used to study transport suspension and 2 ml of 200 g/ml phytohemagglutinin-P and subcellular distribution of fluorescent drugs. As cellular (Difco Laboratories, Detroit, MI, USA). After 72 h incubation retention and distribution is related to cytotoxicity, these with mitogenic stimulation, cultures were analyzed for 'functional studies' have the potential to supplement the cell cycle distribution and incubated with the various drug immunocytochemical data and report on the functional combinations. activity of the marker proteins. 15, 16 The SW620/Ad300 cell line is 76-fold more resistant to doxorubicin than the parental line. Prior to Results and discussion experimentation, the SW620/Ad300 cell line was grown in doxorubicin-free medium for 7 to 10 days.
Heterogeneity and retention of different fluorochromes
In most of the earlier drug efflux functional assays doxorubicin or daumomycin was used for determination of cellular drug Malignant melanoma (FCCM-2) and renal cell carcinoma retention. Rhodamine 123 (Rh-123) was introduced as a fluo-(FCCR-2):
These cell lines were established in our laborarochrome for functional assays due to its excellent fluorescent tory from patient biopsies obtained for diagnostic purposes.
qualities. 18 Frey et al 19 ochrome and identifying the subpopulations which differ in dye retention either due to efflux or other characteristics.
Drug retention experiments Drug retention and efflux in normal human peripheral
Cells were harvested and resuspended at an approximate conblood lymphocytes centration of 10 6 per ml of medium. Fluorochromes and efflux blockers from stock solutions were added and the incubation Drug efflux and sensitivity to efflux blockers (which inhibit continued for 30 to 60 min in a humidified atmosphere of efflux and enhance cellular drug retention and 95% air and 5% CO 2 . chemosensitivity) is predominantly seen in drug resistant tumor cells. P-glycoprotein expression has been reported in a variety of normal cells such as capillary endothelial cells of
P-gp expression
brain and testes, adrenals, liver and CD34-positive bone marrow stem cells. 20, 21 Although normal human peripheral blood lymphocytes were earlier reported to have no P-gp or mdr1 For staining of cells with the C219 antibody, the methods earlier described were used. 10 The method described by Arceci et mRNA expression, subsequent studies have shown that a significant percentage of peripheral blood lymphocytes have Pal 12 was used for determination of cell surface P-glycoprotein expression with 4E3 monoclonal antibody. For staining with gp expression and efflux which can be blocked by P-gp antibodies. Dot plots in Figure 2 are of human peripheral blood MRK16 antibody, cells were washed with Ca good as SY-38 for identifying the drug effluxing peripheral than that of the subpopulation in unstimulated lymphocytes. These observations are important in the study of leukemic blood lymphocytes. (2) In normal human peripheral blood lymphocytes, a significant (50%) population with reduced SYpopulations where one may have subpopulations of normal lymphocytes with pronounced drug efflux intermixed with 38 or SY-3150 retention can increase dye retention by incubation with efflux blockers. (3) In stimulated lymphoblasts, leukemic cells. It is evident that the multiparametric flow cytometry utilizing other phenotypic markers may be essential to drug efflux and sensitivity to efflux blockers is less pronounced distinguish between the tumor and the normal cells.
In Figure 3a and e dot plots of murine leukemic P388 cells and the drug-resistant P388/R-84 incubated with daunomycin The reader is referred to earlier publications identifying the phenotypic markers of the drug effluxing lymphocytes in the show pronounced heterogeneity in drug retention. The P388/R84 population had at least five distinct subpopulations peripheral blood. 22, 23 based on the FSC vs SSC dot plots of Figure 3e . Figure 3b shows that single parameter histograms which are commonly used to show drug retention and modulation, do not accu-
Heterogeneity of drug retention and contribution of dead or membrane permeable cells
rately reflect the presence of this heterogeneity. To discriminate between the cells with low retention (presumed to be resistant), cells with high retention and cells with damaged Earlier studies have described heterogeneity in retention of fluorochromes and the differential response of subpopulations membranes (which can not efflux the drug), we added isotonic propidium iodide (25 g/ml in Hanks' balanced salt solution) to the efflux blocking activity. 6 Experimental data in Figure 3 shows that contamination of the samples with membrane to the cultures to mark the membrane permeable cells. Dot plots of Figure 3c and the histogram in Figure 3d , show that permeable cells can be a major source of artifacts in drug retention functional assays.
this procedure can enhance distinction between the mem- concentration was critical for obtaining maximum discrimination between retention in the sensitive and the resistant In P388/R84 cells (Figure 3e-h ) heterogeneity is more pronounced as most of the drug-resistant live cells efflux DNR cell lines. In the CEM: CEM/VLB 100 paired cell line, the order was SYwhile the membrane permeable cells (in Figure 3g -h) stain with propidium iodide and stand out as distinct populations 3150 Ͼ SY-38 Ͼ Rh-123 Ͼ DNR. In SW620:Ad300 paired cell line, SY-3150 was the best indicator dye followed by SYwith high cellular fluorescence. This experiment shows that one can easily distinguish between the real heterogeneity of 38. Rh-123 and DNR showed less than . log difference in the mean fluorescence channel values of the sensitive and the drug retention in a tumor population and the artifacts created by the presence of cells with dye permeable (leaky) memresistant cells. branes by the procedures described.
Do fluorochromes differ in their potential for Need for titration of different efflux blockers differentiating between the sensitive and the resistant sub-populations?
In general drug resistant cell lines are resistant to the cytotoxic activity of higher concentrations of efflux blockers. However, We often encounter tumor cells which differ in their capacity in several tumor specimens, we have noted a significant to transport and retain different fluorochromes. These differincrease in the number of dead cells upon incubation with an ences may be determined by differences in influx, modes of efflux blocker and a fluorochrome. To avoid this artifact, one transport (passive vs carrier mediated), energy requirements must titrate concentration of the efflux blocker against a partifor influx, efflux, cell cycle stage, proliferation 24 and the seleccular cell line or tumor specimen to identify concentrations tivity of the efflux mechanism.
which will block efflux and enhance retention without damagData in Figure 4 was generated from three different pairs of ing the cell membrane (which may result in enhanced drug parental and drug-resistant cell lines incubated with DNR, Rhretention and artifacts). In P388/R84 cells, incubated with DNR or Rh-123, both Cmz and Dpd blocked efflux and enhanced retention (Figure 5a,b) . In cells incubated with SY-38 (Figure 5c ), or SY-3150 (Figure 6d ) Dpd was not as good as Cmz in blocking efflux.
In CEM/VLB 100 cells, a lot more variability in the effect of different efflux blockers on the retention of different fluorochromes was seen (Figure 5e-h ). In this cell line, Dpd was uniformly better in blocking efflux and increasing retention of the four different fluorochromes. In SW620/Ad300 cells, a similar Table 1 or the 4E3 monoclonal antibody (solid) are shown.
should serve to illustrate some of the problems in reporting and comparison of statistical data from isotype and antibody treated samples. In histograms such as those of CEM/VLB 100 Figure 8c and of SW620/Ad300 in Figure 8b pose a problem due to the presence of 'long trailing ends' of the histograms. One of the major concerns in quantitating P-gp expression in tumor cells analyzed by laser flow cytometry is lack of a common agreed upon method which could allow for data comparison. We have used and advocated the following analtyical procedure for reporting of data for comparative purposes. After data in list mode is collected from both the isotype controls and the antibody reacted samples, electronic gates are set on the isotype control to exclude 95% of cells recorded in the FITC or fluorescence channels. These gates are then copied on the antibody-stained samples and the number of cells failling outside the gate are recorded as being positive. Simultaneously, the mean fluorescence channel value of the isotype and the antibody reacted specimen is determined to arrive at a ratio of the two. This procedure has the advantage of not only determining as to what percentage of cells have positive expression, but also indicating the intensity of antigen reactivity. As most of the data analysis systems on the currently available flow cytometers have the technical capabilities of setting electronic gates and rapidly determining the value for comparative studies. This may be especially important when one wants to compare antigen expression in sequential clinical samples of a patient over a period of time.
